Bristol Myers Squibb to Invest $40 Billion in U.S. Research and Manufacturing Over Five Years

Bristol Myers Squibb (BMS) announced plans to invest $40 billion in the United States over the next five years. The pharmaceutical company intends to strengthen its research and manufacturing operations within the country. The investment will be allocated to enhance BMS’s existing infrastructure and support the development of new technologies. These efforts will expand the company’s capabilities in both research and production. The aim is to ensure that the pharmaceutical company can continue developing and manufacturing medicines within the United States, according to the company.

Newsflash | Powered by GeneOnline AI
Date: May 6, 2025

Author

Mark Chiang